Skip to Main Content

Author Details

Roula Albadine
Centre hospitalier de l'Universite de Montreal
2006
51
25
PMIDPaper TitleJournal TitlePublished Year
37434650Ectopic ACTH Cushing's syndrome caused by a large-cell neuroendocrine lung carcinoma responding to desmopressin.Endocr Oncol2023
33402551A randomized noninferiority trial comparing the diagnostic yield of the 25G ProCore needle to the standard 25G needle in suspicious pancreatic lesions.Endosc Ultrasound2021
33498159Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC.Curr Oncol2021
34944863Identification of Morphologic Criteria Associated with Biochemical Recurrence in Intraductal Carcinoma of the Prostate.Cancers (Basel)2021
34509095Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer.Lung Cancer2021
34743445Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.J Biomed Opt2021
32341866Wide-field optical spectroscopy system integrating reflectance and spatial frequency domain imaging to measure attenuation-corrected intrinsic tissue fluorescence in radical prostatectomy specimens.Biomed Opt Express2020
32797086Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.PLoS Med2020
32304736Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLC.J Thorac Oncol2020
29271792Hematoxylin and Eosin Counterstaining Protocol for Immunohistochemistry Interpretation and Diagnosis.Appl Immunohistochem Mol Morphol2019
31548824Crizotinib inhibition of <i>ROS1-</i>positive tumours in advanced non-small-cell lung cancer: a Canadian perspective.Curr Oncol2019
31018850Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.Radiat Oncol2019
29603326The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival.Prostate2018
30464681Canadian perspectives: update on inhibition of <i>ALK</i>-positive tumours in advanced non-small-cell lung cancer.Curr Oncol2018
29542855Mesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeutics.BJU Int2018
27448147Endoscopic ultrasound-guided FNA of pelvic lesions: A large single-center experience.Cancer Cytopathol2016
27330348Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.Curr Oncol2016
26178158PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.Prostate2015
24315206Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms.Hum Pathol2014
25122422Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer.J Thorac Oncol2014
24769028GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.J Urol2014
24035134Activation of mammalian target of rapamycin signaling pathway markers in minute adenocarcinoma of the prostate.Urology2013
24071011The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.Hum Pathol2013
23953228Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomas.Hum Pathol2013
21396836Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.Urol Oncol2012
22684219Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer.Mod Pathol2012
22542128Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomas.Hum Pathol2012
22424560Renal cell carcinoma associated with peritumoral sarcoid-like reaction without intratumoral granuloma.Diagn Pathol2012
22406363High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues.Hum Pathol2012
21820147Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center.Hum Pathol2012
21263247PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.Am J Surg Pathol2011
21821730Improved bioavailability of epoxyeicosatrienoic acids reduces TP-receptor agonist-induced tension in human bronchi.Am J Physiol Lung Cell Mol Physiol2011
21784969NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues.Am J Physiol Lung Cell Mol Physiol2011
21881486Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas.Am J Surg Pathol2011
21743434Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.Mod Pathol2011
21677539Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.Am J Surg Pathol2011
21317652Total liquid ventilation efficacy in an ovine model of severe meconium aspiration syndrome.Crit Care Med2011
2000828317,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.Am J Respir Cell Mol Biol2010
21138874Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment.Clin Cancer Res2010
20679884Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.Am J Surg Pathol2010
20501622A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer.Clin Cancer Res2010
20463571PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract.Am J Surg Pathol2010
20601956Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements.Nat Genet2010
20172544Extracellular matrix associated protein CYR61 is linked to prostate cancer development.J Urol2010
19157440Phosphorylated H2AX in noninvasive low grade urothelial carcinoma of the bladder: correlation with tumor recurrence.J Urol2009
19734849TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.Mod Pathol2009
19539329Topoisomerase II alpha status in renal medullary carcinoma: immuno-expression and gene copy alterations of a potential target of therapy.J Urol2009
19151660TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.Mod Pathol2009
18622385Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors.Mod Pathol2008
17968929Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation.Arthritis Rheum2007
  • 1 - 50 of 51

Recommended Authors

Jacqueline Fontugne
Institut Curie, CNRS, PSL Research University
Career Start Year 2013
Number of shared co-authors 0
Steven Hazell
Royal Marsden NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 5
Kyung Park
New York University Langone Health
Career Start Year 2010
Number of shared co-authors 0
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 5
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 0
Fadi Brimo
McGill University Health Centre, McGill University
Career Start Year 2007
Number of shared co-authors 16
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 7
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 12
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 7
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 10
Adeboye O Osunkoya
Emory University School of Medicine
Career Start Year 2002
Number of shared co-authors 12
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 6
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 3
Rohit Mehra
Michigan Center for Translational Pathology.
Career Start Year 2000
Number of shared co-authors 12
Anuradha Gopalan
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 14
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 8
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 2
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 11
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 7
David Clouston
Career Start Year 1995
Number of shared co-authors 5
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 5
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Holger Moch
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 7
Nallasivam Palanisamy
Vattikuti Urology Institute
Career Start Year 1990
Number of shared co-authors 4
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 17
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 10
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 1
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 6
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 14
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 5

Collaborators

Dominique Trudel
Institut du cancer de Montreal
Co-authored papers 8
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 8
Fred Saad
University of Montreal Health Center
Co-authored papers 7
Pedram Argani
The Johns Hopkins Hospital
Co-authored papers 7
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 6
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 5
Mirela Birlea
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 5
Alain Bergeron
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers 5
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers 5
Andr??e-Anne Grosset
Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM)
Co-authored papers 5
Andr?? Kougioumoutzakis
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 4
Nazim Benzerdjeb
Institut de Pathologie Multisite
Co-authored papers 4
Michael A Carducci
Johns Hopkins School of Medicine
Co-authored papers 4
Frederic Leblond
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 4
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 4
Kelly Aubertin
INSERM UMR_S9 and Universite de Strasbourg, Institut d'immunologie et d'hematologie
Co-authored papers 3
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 3
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 3
Michael C Haffner
Fred Hutchinson Cancer Center
Co-authored papers 3
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 3
Herv?? Brisson
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Co-authored papers 2
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 2
Samuel Kadoury
Centre de recherche du Centre Hospitalier de l'Universite de Montreal
Co-authored papers 2
Susan Prendeville
University of Toronto
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Keith Kwan
Western University
Co-authored papers 2
Robert G Bristow
University of Toronto
Co-authored papers 2
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 2
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Release 1.2